Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival

INTRODUCTION: Metastatic breast cancer (MBC) with leptomeningeal metastases (LM) has dismal survival. We aim to determine if modern systemic therapy, especially the bevacizumab, cisplatin, and etoposide (BEEP) regimen, is beneficial to MBC LM patients. METHODS: We excerpted data from a prospectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Tom Wei-Wu, Jan, I-Shiow, Chang, Dwang-Ying, Lin, Ching-Hung, Chen, I-Chun, Chen, Ho-Min, Cheng, Ann-Lii, Lu, Yen-Shen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280357/
https://www.ncbi.nlm.nih.gov/pubmed/32346837
http://dx.doi.org/10.1007/s11060-020-03510-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280357/
https://www.ncbi.nlm.nih.gov/pubmed/32346837
http://dx.doi.org/10.1007/s11060-020-03510-y

Ejemplares similares